Dose-dense cisplatin/paclitaxel

This publication has 23 references indexed in Scilit:

• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI Journal of the National Cancer Institute, 2000
• Increased Nephrotoxicity of Combination Taxol and Cisplatin Chemotherapy in Gynecologic Cancers as Compared to Cisplatin Alone
  American Journal of Nephrology, 1997
• The role of high-dose chemotherapy in the management of advanced ovarian cancer
  Current Opinion in Oncology, 1996
• A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer
  Gynecologic Oncology, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration
  European Journal Of Cancer, 1995
• Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
  The Lancet, 1992
• Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy
  European Journal of Cancer and Clinical Oncology, 1991
• Long-term survival in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Alterations in the toxicity of cis-Dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration
  Toxicology and Applied Pharmacology, 1981